Apogee Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(3.4%),Peter Kolchinsky(3.4%)等
Apogee Therapeutics | SC 13G:超过5%持股股东披露文件-DRIEHAUS CAPITAL MANAGEMENT LLC(5.63%)
Apogee Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(2.22%),Deep Track Biotechnology Master Fund, Ltd.(2.22%)等
Apogee Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(16.672%),Abigail P. Johnson(16.672%)
Apogee Therapeutics | 4:持股变动声明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股变动声明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.6%)
Apogee Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-AI Biotechnology LLC(4.87%),Access Industries Holdings LLC(4.87%)等
Apogee Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.6%)
Apogee Therapeutics | 4:持股变动声明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股变动声明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | SC 13G:超过5%持股股东披露文件-Wellington Management Group LLP(10.70%),Wellington Group Holdings LLP(10.70%)等
Apogee Therapeutics | 4:持股变动声明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股变动声明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4:持股变动声明-高管 Henderson Jane
Apogee Therapeutics | 4:持股变动声明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股变动声明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4:持股变动声明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4:持股变动声明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股变动声明-董事 JONES WILLIAM A JR
暂无数据
暂无数据